154 related articles for article (PubMed ID: 8252482)
41. Prognostic factors of early stage cervical cancer treated by radical hysterectomy.
Sevin BU; Nadji M; Lampe B; Lu Y; Hilsenbeck S; Koechli OR; Averette HE
Cancer; 1995 Nov; 76(10 Suppl):1978-86. PubMed ID: 8634988
[TBL] [Abstract][Full Text] [Related]
42. [Risk factors and prognosis of node-positive cervical carcinoma].
Feng SY; Zhang YN; Liu JG
Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
[TBL] [Abstract][Full Text] [Related]
43. Deoxyribonucleic acid ploidy and S-phase fraction are not significant prognostic factors for patients with cervical cancer.
Jelen I; Valente PT; Gautreaux L; Clark GM
Am J Obstet Gynecol; 1994 Dec; 171(6):1511-6; discussion 1516-8. PubMed ID: 7802060
[TBL] [Abstract][Full Text] [Related]
44. Evidence of tumor heterogeneity in cervical cancers and lymph node metastases as determined by flow cytometry.
Nguyen HN; Sevin BU; Averette HE; Ramos R; Ganjei P; Perras J
Cancer; 1993 Apr; 71(8):2543-50. PubMed ID: 8453577
[TBL] [Abstract][Full Text] [Related]
45. Safety of ovarian preservation in women with stage I and II cervical adenocarcinoma: a retrospective study and meta-analysis.
Chen J; Wang R; Zhang B; Lin X; Wei J; Jia Y; Yin Y; Ye S; Zhu T; Chen G; Yuan Y; Lu W; Li K
Am J Obstet Gynecol; 2016 Oct; 215(4):460.e1-460.e13. PubMed ID: 27133009
[TBL] [Abstract][Full Text] [Related]
46. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.
Uno T; Ito H; Itami J; Yasuda S; Isobe K; Hara R; Sato T; Minoura S; Shigematsu N; Kubo A
Anticancer Res; 2000; 20(3B):2235-9. PubMed ID: 10928184
[TBL] [Abstract][Full Text] [Related]
47. The role of DNA index as a prognostic factor in early cervical carcinoma.
Nguyen HN; Sevin BU; Averette HE; Ganjei P; Perras J; Ramos R; Angioli R; Donato D; Penalver M
Gynecol Oncol; 1993 Jul; 50(1):54-9. PubMed ID: 8349165
[TBL] [Abstract][Full Text] [Related]
48. Prospective analysis of DNA ploidy, proliferative index and epidermal growth factor receptor as prognostic factors for pretreated uterine cancer.
Nagai N; Oshita T; Fujii T; Kioka H; Katsube Y; Ohama K
Oncol Rep; 2000; 7(3):551-9. PubMed ID: 10767367
[TBL] [Abstract][Full Text] [Related]
49. DNA ploidy status as a prognostic marker and predictor of lymph node metastasis in laryngeal carcinoma.
Takes RP; Baatenburg de Jong RJ; van Blommestein R; Hermans J; van Krieken HH; Cornelisse CJ
Ann Otol Rhinol Laryngol; 2002 Nov; 111(11):1015-20. PubMed ID: 12450177
[TBL] [Abstract][Full Text] [Related]
50. Isolated full-thickness cervical stromal invasion warrants post-hysterectomy pelvic radiotherapy in FIGO stages IB-IIA uterine cervical carcinoma.
Moon SH; Wu HG; Ha SW; Lee HP; Kang SB; Song YS; Park NH; Kim JW; Park IA; Kim BH
Gynecol Oncol; 2007 Jan; 104(1):152-7. PubMed ID: 16935323
[TBL] [Abstract][Full Text] [Related]
51. Clinical significance of intratumoral blood flow in cervical carcinoma assessed by color Doppler ultrasound.
Hsieh CY; Wu CC; Chen TM; Chen CA; Chen CL; Wang JF; Chang CF; Hsieh FJ
Cancer; 1995 May; 75(10):2518-22. PubMed ID: 7736396
[TBL] [Abstract][Full Text] [Related]
52. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy.
Kamura T; Shigematsu T; Kaku T; Shimamoto T; Saito T; Sakai K; Mitsumoto M; Nakano H
Acta Obstet Gynecol Scand; 1999 May; 78(5):452-7. PubMed ID: 10326894
[TBL] [Abstract][Full Text] [Related]
53. Cell cycle flow cytometric analysis in the diagnosis and management of colorectal carcinoma.
Sampedro A; Salas-Bustamante A; López-Artimez M; García-Muñíz JL; Urdiales G
Anal Quant Cytol Histol; 1999 Aug; 21(4):347-52. PubMed ID: 10560513
[TBL] [Abstract][Full Text] [Related]
54. Flow cytometry in cervical adenocarcinoma. Correlating DNA content analysis with the clinical picture.
Kaspar HG; Dinh TV; Hannigan EV
J Reprod Med; 1997 Mar; 42(3):170-2. PubMed ID: 9109087
[TBL] [Abstract][Full Text] [Related]
55. Prognostic significance of DNA image cytometry in Libyan breast cancer.
Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
[TBL] [Abstract][Full Text] [Related]
56. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
57. Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy.
Kamura T; Tsukamoto N; Tsuruchi N; Saito T; Matsuyama T; Akazawa K; Nakano H
Cancer; 1992 Jan; 69(1):181-6. PubMed ID: 1727662
[TBL] [Abstract][Full Text] [Related]
58. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM
Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
[TBL] [Abstract][Full Text] [Related]
59. Human papillomavirus type 16 in tumor tissue of low-stage squamous carcinoma of the uterine cervix in relation to ploidy grade and prognosis.
Kenter GG; Cornelisse CJ; Jiwa NM; Aartsen EJ; Hermans J; Mooi W; Heintz AP; Fleuren GJ
Cancer; 1993 Jan; 71(2):397-401. PubMed ID: 8380752
[TBL] [Abstract][Full Text] [Related]
60. Prognostic value of DNA ploidy in breast cancer stage I-II.
Cufer T; Lamovec J; Bracko M; Lindtner J; Us-Krasovec M
Neoplasma; 1997; 44(2):127-32. PubMed ID: 9201293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
